Could a cancer drug help beat malaria? new trial aims to find out
NCT ID NCT07559370
First seen May 05, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study tests whether adding imatinib (a drug used for certain cancers) to the standard malaria treatment can clear the parasite faster and help stop drug resistance. About 1,100 adults with mild to moderate malaria will receive either the standard 3-day treatment or a shorter 2-day combo. The goal is to see if the combo is safe, works faster, and reduces the chance of the infection coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA (PLASMODIUM FALCIPARUM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Victoria Biomedical Research Institute
RECRUITINGKisumu, 40100, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.